PAR
Click for more information
1.61% 30.5¢ paradigm biopharmaceuticals limited..

Worse Case, page-31

  1. Gan_Gans
    2,121 Posts.
    lightbulb Created with Sketch. 568
    clock Created with Sketch.
    10/02/22
    14:39
    Post #: 59487010
    True - but the guidance is for acute not chronic pain and also, its up to Paradigm a bit - why the hell haven't they applied for a FastTrack designation is beyond me. Yes, it comes into play at NDA time, but would do a lot for investor confidence.
    PAR Price at posting: $1.43 Sentiment: Buy Disclosure: Held
    Likes Created with Sketch. 6  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

NEWS Bitcoin investors need to know the risks
right-arrow Created with Sketch.
NEWS ASX hits all time high out the gate on Friday trades following bullish US inflation data
right-arrow Created with Sketch.
SKS SKS Technologies wins US$90M award to supply power to international hyperscale data centre in Melbourne
right-arrow Created with Sketch.
NIM Nimy to raise $1.21M to explore 'newsy' WA targets
right-arrow Created with Sketch.
GED Golden Deeps eyes prospective Cu-Au tenements in NSW with HOA
right-arrow Created with Sketch.
TLX Telix jumps 11.6% as US government indicates proposed medicare changes won't affect prostate cancer drug
right-arrow Created with Sketch.
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
(20min delay)
Last
30.5¢ 		Change
-0.005(1.61%) 		Mkt cap ! $108.4M
Open High Low Value Volume
31.0¢ 31.5¢ 30.5¢ $83.77K 268.2K

Buyers (Bids)

No. Vol. Price($)
6 23559 30.0¢
 

Sellers (Offers)

Price($) Vol. No.
31.5¢ 12380 3
View Market Depth
Last trade - 10.54am 15/07/2024 (20 minute delay) ?
PAR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.